LIGAND SPECIFICITIES OF RECOMBINANT RETINOIC ACID RECEPTORS RAR-ALPHA AND RAR-BETA

被引:152
作者
CRETTAZ, M
BARON, A
SIEGENTHALER, G
HUNZIKER, W
机构
[1] F HOFFMANN LA ROCHE & CO LTD,DEPT PHARMACEUT RES,CH-4002 BASEL,SWITZERLAND
[2] UNIV GENEVA,HOP CANTONAL,DERMATOL CLIN,CH-1211 GENEVA 4,SWITZERLAND
[3] F HOFFMANN LA ROCHE & CO LTD,CENT RES UNIT,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1042/bj2720391
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Binding of retinoic acid (RA) to specific RA receptors α and β (RARα and RARβ) was studied. Receptors were obtained in two ways: (1) full-length receptors were produced by transient expression of the respective human cDNAs in COS 1 cells; and (2) the ligand-binding domains of RARα and RARβ were produced in Escherichia coli. RA binding to the wild-type and truncated forms of the receptor was identical for both RARα and RARβ, indicating that the ligand-binding domains have retained the binding characteristics of the intact receptors. Furthermore, RA bound with the same affinity to both RARα and RARβ. Only retinoid analogues with an acidic end-group were able to actively bind to both receptors. On measuring the binding of various retinoids, we have found that the properties of the ligand-binding sites of RARα and RARβ were rather similar. Two retinoid analogues were capable of binding preferentially to either RARα or RARβ, suggesting that it may be possible to synthesize specific ligands for RARα and RARβ.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 36 条
[21]  
LIPPMAN SM, 1987, CANCER TREAT REP, V71, P391
[22]   ALL-TRANS-RETINAL STIMULATES SUPEROXIDE RELEASE AND PHOSPHOLIPASE-C ACTIVITY IN NEUTROPHILS WITHOUT SIGNIFICANTLY BLOCKING PROTEIN-KINASE-C [J].
LOCHNER, JE ;
BADWEY, JA ;
HORN, W ;
KARNOVSKY, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (20) :7673-7677
[23]   LIGAND - A VERSATILE COMPUTERIZED APPROACH FOR CHARACTERIZATION OF LIGAND-BINDING SYSTEMS [J].
MUNSON, PJ ;
RODBARD, D .
ANALYTICAL BIOCHEMISTRY, 1980, 107 (01) :220-239
[24]   IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR RETINOIC ACID-BINDING ACTIVITY IN HUMAN MYELOBLASTIC-LEUKEMIA HL-60 CELLS [J].
NERVI, C ;
GRIPPO, JF ;
SHERMAN, MI ;
GEORGE, MD ;
JETTEN, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5854-5858
[25]   THE RETINOIDS - A REVIEW OF THEIR CLINICAL-PHARMACOLOGY AND THERAPEUTIC USE [J].
ORFANOS, CE ;
EHLERT, R ;
GOLLNICK, H .
DRUGS, 1987, 34 (04) :459-503
[26]   A HUMAN RETINOIC ACID RECEPTOR WHICH BELONGS TO THE FAMILY OF NUCLEAR RECEPTORS [J].
PETKOVICH, M ;
BRAND, NJ ;
KRUST, A ;
CHAMBON, P .
NATURE, 1987, 330 (6147) :444-450
[27]   EXPRESSION OF THE ALPHA-RETINOIC AND BETA-RETINOIC ACID RECEPTORS IN SKIN [J].
REES, JL ;
REDFERN, CPF .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (06) :818-820
[28]  
ROBERTS AB, 1984, RETINOIDS, V2, P209
[29]  
SHERMAN MI, 1986, RETINOIDS CELL DIFFE, P161
[30]  
SMITH TJ, 1989, J BIOL CHEM, V264, P687